Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Constantinescu

Showing results (141-150 of 180) with videos related to

Pageof 18
Sort By:
Combinatorial Chemistry & High Throughput Screening|October 18, 2016
A Phenotypic Screen for Small-Molecule Inhibitors of Constitutively Active Mutant Thrombopoietin Receptor Implicated in Myeloproliferative NeoplasmsAnna Ngo, Ann Zhufang Koay, Christian Pecquet, et al.
Leukemia|September 1, 2019
Knock-in of murine Calr del52 induces essential thrombocythemia with slow-rising dominance in mice and reveals key role of Calr exon 9 in cardiac developmentThomas Balligand, Younes Achouri, Christian Pecquet, et al.
Oncogene|April 1, 2014
Persistent STAT5 activation in myeloid neoplasms recruits p53 into gene regulationM Girardot, C Pecquet, I Chachoua, et al.
Nature|March 29, 2005
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia veraChloé James, Valérie Ugo, Jean-Pierre Le Couédic, et al.
Blood|December 10, 2009
Induction of myeloproliferative disorder and myelofibrosis by thrombopoietin receptor W515 mutants is mediated by cytosolic tyrosine 112 of the receptorChristian Pecquet, Judith Staerk, Ronan Chaligné, et al.
Blood|March 2, 2012
Thrombopoietin receptor down-modulation by JAK2 V617F: restoration of receptor levels by inhibitors of pathologic JAK2 signaling and of proteasomesChristian Pecquet, Carmen C Diaconu, Judith Staerk, et al.
Virologie|April 1, 1977
Incidence of hepatitis B surface antigen (HBsAg) in some areas of RomaniaN Steiner, V T Babeş, C Berca, et al.
Journal of Cellular and Molecular Medicine|November 21, 2013
Combination treatment for myeloproliferative neoplasms using JAK and pan-class I PI3K inhibitorsMeng Ling Choong, Christian Pecquet, Vishal Pendharkar, et al.
Hemasphere|June 16, 2021
Induced Pluripotent Stem Cells Enable Disease Modeling and Drug Screening in Calreticulin del52 and ins5 Myeloproliferative NeoplasmsLise Secardin, Cintia Gomez Limia, Suzana da Silva-Benedito, et al.
Blood|December 31, 2016
An incomplete trafficking defect to the cell-surface leads to paradoxical thrombocytosis for human and murine MPL P106LFabrizia Favale, Kahia Messaoudi, Leila N Varghese, et al.
Pageof 18

Showing results (141-150 of 180) with videos related to

Sort By:
Pageof 18
Combinatorial Chemistry & High Throughput Screening|October 18, 2016
A Phenotypic Screen for Small-Molecule Inhibitors of Constitutively Active Mutant Thrombopoietin Receptor Implicated in Myeloproliferative NeoplasmsAnna Ngo, Ann Zhufang Koay, Christian Pecquet, et al.
Leukemia|September 1, 2019
Knock-in of murine Calr del52 induces essential thrombocythemia with slow-rising dominance in mice and reveals key role of Calr exon 9 in cardiac developmentThomas Balligand, Younes Achouri, Christian Pecquet, et al.
Oncogene|April 1, 2014
Persistent STAT5 activation in myeloid neoplasms recruits p53 into gene regulationM Girardot, C Pecquet, I Chachoua, et al.
Nature|March 29, 2005
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia veraChloé James, Valérie Ugo, Jean-Pierre Le Couédic, et al.
Blood|December 10, 2009
Induction of myeloproliferative disorder and myelofibrosis by thrombopoietin receptor W515 mutants is mediated by cytosolic tyrosine 112 of the receptorChristian Pecquet, Judith Staerk, Ronan Chaligné, et al.
Blood|March 2, 2012
Thrombopoietin receptor down-modulation by JAK2 V617F: restoration of receptor levels by inhibitors of pathologic JAK2 signaling and of proteasomesChristian Pecquet, Carmen C Diaconu, Judith Staerk, et al.
Virologie|April 1, 1977
Incidence of hepatitis B surface antigen (HBsAg) in some areas of RomaniaN Steiner, V T Babeş, C Berca, et al.
Journal of Cellular and Molecular Medicine|November 21, 2013
Combination treatment for myeloproliferative neoplasms using JAK and pan-class I PI3K inhibitorsMeng Ling Choong, Christian Pecquet, Vishal Pendharkar, et al.
Hemasphere|June 16, 2021
Induced Pluripotent Stem Cells Enable Disease Modeling and Drug Screening in Calreticulin del52 and ins5 Myeloproliferative NeoplasmsLise Secardin, Cintia Gomez Limia, Suzana da Silva-Benedito, et al.
Blood|December 31, 2016
An incomplete trafficking defect to the cell-surface leads to paradoxical thrombocytosis for human and murine MPL P106LFabrizia Favale, Kahia Messaoudi, Leila N Varghese, et al.
Pageof 18